← Back
$ESPR All transactions

Esperion Therapeutics, Inc.

▼ SELL

$ Value

$20K

Shares

7,046

Price

$3

Filed

Sep 18

Insider

Name

Halladay Benjamin

Title

Chief Financial Officer

CIK

0001953943

Roles

Officer

Transaction Details

Transaction Date

2025-09-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

474,862

Footnotes

Shares were sold to satisfy tax obligation on vested shares of restricted stock units. | Includes 7,446 shares recently acquired in Esperion's Employee Stock Purchase Plan.

Filing Info

Accession No.

0001953943-25-000004

Form Type

4

Issuer CIK

0001434868

Halladay Benjamin's History

Date Ticker Type Value
2026-03-17 ESPR $17K
2026-03-13 ESPR A $0
2026-03-13 ESPR A $0
2025-12-17 ESPR $27K
2025-09-17 ESPR $20K
2025-07-17 ESPR $12
2025-06-17 ESPR $8K

Other Insiders at ESPR (90d)

Insider Bought Sold Last
Koenig Sheldon L.
President and CEO
$70K 2026-03-17
Looker Benjamin
Chief Legal Officer
$15K 2026-03-17
Halladay Benjamin
Chief Financial Officer
$17K 2026-03-17